Wellington Management Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Wellington Management Group’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.42B	Buy	1,837,459 +1,172,994	+177%	+$898M	0.27%	86
2025 Q4	$513M	Buy	664,465 +656,845	+8,620%	+$446M	0.09%	202
2025 Q3	$4.28M	Sell	7,620 -63,535	-89%	-$35.9M	﹤0.01%	1476
2025 Q2	$37.4M	Buy	71,155 +53,741	+309%	+$30M	0.01%	767
2025 Q1	$11M	Sell	17,414 -131,415	-88%	-$90.4M	﹤0.01%	1173
2024 Q4	$106M	Sell	148,829 -291,780	-66%	-$245M	0.02%	520
2024 Q3	$463M	Sell	440,609 -621,182	-59%	-$691M	0.08%	213
2024 Q2	$1.12B	Sell	1,061,791 -31,184	-3%	-$30.2M	0.2%	122
2024 Q1	$1.05B	Sell	1,092,975 -9,115	-0.8%	-$8.67M	0.19%	137
2023 Q4	$968M	Sell	1,102,090 -404,795	-27%	-$333M	0.18%	135
2023 Q3	$1.24B	Sell	1,506,885 -162,047	-10%	-$127M	0.25%	102
2023 Q2	$1.2B	Sell	1,668,932 -98,987	-6%	-$76.3M	0.23%	105
2023 Q1	$1.45B	Sell	1,767,919 -648,328	-27%	-$489M	0.29%	91
2022 Q4	$1.74B	Sell	2,416,247 -27,042	-1%	-$20M	0.35%	69
2022 Q3	$1.68B	Buy	2,443,289 +60,342	+3%	+$38M	0.36%	71
2022 Q2	$1.41B	Sell	2,382,947 -507,256	-18%	-$330M	0.28%	85
2022 Q1	$2.02B	Sell	2,890,203 -244,572	-8%	-$155M	0.35%	73
2021 Q4	$1.98B	Sell	3,134,775 -233,290	-7%	-$143M	0.32%	75
2021 Q3	$2.04B	Sell	3,368,065 -689,317	-17%	-$428M	0.35%	74
2021 Q2	$2.27B	Buy	4,057,382 +181,002	+5%	+$91.7M	0.38%	70
2021 Q1	$1.83B	Buy	3,876,380 +245,858	+7%	+$120M	0.32%	78
2020 Q4	$1.75B	Buy	3,630,522 +151,995	+4%	+$82M	0.32%	77
2020 Q3	$1.95B	Sell	3,478,527 -185,341	-5%	-$112M	0.4%	66
2020 Q2	$2.28B	Buy	3,663,868 +1,607,109	+78%	+$912M	0.51%	49
2020 Q1	$1B	Sell	2,056,759 -193,156	-9%	-$79.7M	0.27%	88
2019 Q4	$845M	Buy	2,249,915 +481,959	+27%	+$162M	0.18%	132
2019 Q3	$490M	Sell	1,767,956 -11,331	-0.6%	-$3.35M	0.11%	194
2019 Q2	$557M	Sell	1,779,287 -337,435	-16%	-$112M	0.12%	185
2019 Q1	$869M	Sell	2,116,722 -890,904	-30%	-$367M	0.2%	127
2018 Q4	$1.12B	Sell	3,007,626 -1,068,785	-26%	-$391M	0.28%	91
2018 Q3	$1.65B	Sell	4,076,411 -302,068	-7%	-$115M	0.35%	72
2018 Q2	$1.51B	Buy	4,378,479 +56,011	+1%	+$17.5M	0.34%	80
2018 Q1	$1.49B	Sell	4,322,468 -5,221	-0.1%	-$1.82M	0.34%	77
2017 Q4	$1.63B	Sell	4,327,689 -521,145	-11%	-$211M	0.36%	74
2017 Q3	$2.17B	Sell	4,848,834 -692,351	-12%	-$329M	0.5%	51
2017 Q2	$2.72B	Sell	5,541,185 -594,374	-10%	-$260M	0.64%	37
2017 Q1	$2.38B	Buy	6,135,559 +446,850	+8%	+$166M	0.57%	41
2016 Q4	$2.09B	Sell	5,688,709 -1,270,123	-18%	-$483M	0.52%	44
2016 Q3	$2.8B	Buy	6,958,832 +661,614	+11%	+$265M	0.7%	29
2016 Q2	$2.2B	Buy	6,297,218 +84,824	+1%	+$32.7M	0.57%	42
2016 Q1	$2.24B	Buy	6,212,394 +1,426,801	+30%	+$588M	0.59%	38
2015 Q4	$2.6B	Sell	4,785,593 -239,461	-5%	-$130M	0.68%	33
2015 Q3	$2.34B	Sell	5,025,054 -479,494	-9%	-$258M	0.65%	32
2015 Q2	$2.81B	Sell	5,504,548 -286,790	-5%	-$140M	0.72%	27
2015 Q1	$2.61B	Sell	5,791,338 -88,860	-2%	-$37.7M	0.67%	31
2014 Q4	$2.41B	Buy	5,880,198 +43,858	+0.8%	+$17.2M	0.64%	32
2014 Q3	$2.1B	Buy	5,836,340 +166,994	+3%	+$56M	0.58%	34
2014 Q2	$1.6B	Buy	5,669,346 +1,191,241	+27%	+$353M	0.43%	56
2014 Q1	$1.34B	Buy	4,478,105 +152,098	+4%	+$46.9M	0.37%	62
2013 Q4	$1.19B	Buy	4,326,007 +7,251	+0.2%	+$2.09M	0.34%	69
2013 Q3	$1.35B	Sell	4,318,756 -130,700	-3%	-$34.4M	0.42%	57
2013 Q2	$1B	Buy	+4,449,456	New	+$1.04B	0.33%	70

Other funds holding REGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Wellington Management Group's REGN Position: Q1 2026 in Review

Wellington Management Group increased its Regeneron Pharmaceuticals (REGN) stake by 177% in Q1 2026, buying an estimated $898M and bringing the position to 1,837,459 shares worth $1.42B. The position accounts for 0.27% of the portfolio, ranked #86.

Wellington Management Group first reported a position in REGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.81B in Q2 2015. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

Wellington Management Group held 1,837,459 shares of Regeneron Pharmaceuticals worth $1.42B as of Q1 2026.
Wellington Management Group bought 1,172,994 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $898M.
Regeneron Pharmaceuticals made up 0.27% of Wellington Management Group's portfolio in Q1 2026, its #86 holding.
Wellington Management Group first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
Wellington Management Group's Regeneron Pharmaceuticals position peaked at $2.81B in Q2 2015.
1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.